GC19179
GSK2256098
Also known as 2-[[5-chloro-2-[(5-methyl-2-propan-2-ylpyrazol-3-yl)amino]-4-pyridinyl]amino]-N-methoxybenzamide
GSK2256098 is a selective FAK kinase inhibitor, which inhibits growth and survival of pancreatic ductal adenocarcinoma cells
ChemicalCAS1224887-10-8MW414.89FormulaC20H23ClN6O2
- CAS number
- 1224887-10-8
- Molecular weight
- 414.89
- Formula
- C20H23ClN6O2
- Solubility
- DMSO ： ≥ 30 mg/mL (72·31 mM)
- InChIKey
- BVAHPPKGOOJSPU-UHFFFAOYSA-N
- Catalogue number
- GC19179
- Brand
- GLPBIO
Computed properties PubChem CID 46214930 · XLogP 4.5 · TPSA 93.1 Ų · H-bond donors 3
- XLogP
- 4.5
- TPSA
- 93.1 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 7
- Heavy atoms
- 29
SMILES CC1=NN(C(=C1)NC2=NC=C(C(=C2)NC3=CC=CC=C3C(=O)NOC)Cl)C(C)C
Computed descriptors from PubChem (CID 46214930), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il